Analysis of anticoagulant therapy by unfractionated heparin during pregnancy after mechanical valve replacement

Circulation Journal

Volumn 78, Issue 4, 2014, Pages 878-881

  Tanaka, Hiroaki ^a   Tanaka, Kayo ^a   Kamiya, Chizuko ^a   Iwanaga, Naoko ^a   Katsuragi, Shinji ^a   Yoshimatsu, Jun ^a  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Anticoagulant therapy; Mechanical valve replacement; Pregnancy; Unfractionated heparin

Indexed keywords

HEPARIN; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; BIRTH WEIGHT; BLEEDING; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CONTINUOUS INFUSION; FEMALE; FETUS DEATH; GESTATIONAL AGE; HEART VALVE REPLACEMENT; HUMAN; PREGNANCY; PROSTHETIC VALVE THROMBOSIS; SCORING SYSTEM; TREATMENT OUTCOME; UMBILICAL ARTERY;

ADULT; ANTICOAGULANTS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HEMORRHAGE; HEPARIN; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; RETROSPECTIVE STUDIES; THROMBOSIS;

EID: 84897856958     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-1178     Document Type: Article

References (12)

1. Elkayam UR. Anticoagulation in pregnant women with prosthetic heart valves: A double jeopardy. J Am Coll Cardiol 1996; 27: 1704-1706.
2. Katsuragi S. Maternal outcome in pregnancy complicated with pulmonary arterial hypertension. Circ J 2012; 76: 2249-2254.
3. Kamiya CA. Outcome of pregnancy and effects on the right heart in women with repaired tetralogy of Fallot. Circ J 2012; 76: 957-963.
4. Kawamata K. Risk and pregnancy outcome in women with prosthetic mechanical heart valve replacement. Circ J 2007; 71: 211-213.
5. Elkayam U, Singh H, Irani A, Akhter MW. Anticoagulation in pregnant women with prosthetic heart valves. J Cardiovasc Pharmacol Ther 2004; 9: 107-115.
6. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve prostheses. Br Heart J 1994; 71: 196-201.
7. Meschengieser SS, Fondevila CG, Santarelli MT, Lazzari MA. An-ticoagulation in pregnant women with mechanical heart valve pros-theses. Heart 1999; 82: 23-26.
8. Salazar E, Izaguirre R, Verdejo J, Mutchinick O. Failure of adjusted doses of subcutaneous heparin to prevent thromboembolic phenomena in pregnant patients with mechanical cardiac valve prostheses. J Am Coll Cardiol 1996; 27: 1698-1703.
9. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: A systematic review of the literature. Arch Internal Med 2000; 160: 191-196.
10. Decousus HA, Croze M, Levi FA, Jaubert JG, Perpoint BM, De Bonadona JF, et al. Circadian changes in anticoagulant effect of hepa-rin infused at a constant rate. BMJ 1985; 290: 341-344.
11. Vitale N, De Feo M, De Santo LS, Pollice A, Tedesco N, Cotrufo M. Dose-dependent fetal complications of warfarin in pregnant women with mechanical heart valves. J Am Coll Cardiol 1999; 33: 1637-1641.
12. Takahashi H, Wilkinson GR, Nutescu EA, Morita T, Ritchie MD, Scordo MG, et al. Different contributions of polymorphisms in VKORC1 and CYP2C9 to intra- and inter-population differences in maintenance dose of warfarin in Japanese, Caucasians and African-Americans. Pharmacogenet Genomics 2006; 16: 101-110.